Paving the way for new depression treatments, researchers have discovered the first-ever connection between vulnerability to depression and a type of brain cells called noradrenergic neurons.
Noradrenergic neurons are located in a cerebral structure named Locus coeruleus. These neurons communicate with each other using noradrenaline, a neurotransmitter molecule involved in emotional regulation, sleep and mood disorders - and, the researchers now believe, resilience and depression.
By combining pharmacological, genetic and optogenetic (activation of the neurons activity by a light beam) approaches, the research team showed that animals that cannot release noradrenaline are systematically vulnerable to depression following chronic stress.
"It is this control that steers the body's response toward resilience or toward vulnerability to depression," said one of the researchers Bruno Giros, professor of psychiatry at McGill University in Montreal, Canada.
This is not, however, an irreversible condition: increasing noradrenaline production results in higher resilience - and less depression, the study said.
Stressful life events--job loss, accident, death of a loved one--can trigger major depression in one person, but not in another.
A deciding factor is resilience, a biological mechanism that determines an individual's capacity to rebound from stressful or traumatic events.
The new findings shed light on how resilience works.
"Beyond this discovery about the brain mechanisms involved in depression, our results help explain how adrenergic drugs may work and could be used to treat major depression," Giros said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
